Press Releases

TARRYTOWN, N.Y., Aug. 6, 2019 /PRNewswire/ ---- Second quarter 2019 revenues increased 20% to $1.93 billion versus second quarter 2018EYLEA® U.S. net sales increased 17% to $1.16 billion versus second quarter 2018 Dupixent® global net s

MINNEAPOLIS, Aug. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2019. The quarterly dividend will be payable August 30, 2019 to all common shar

MINNEAPOLIS, Aug. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2019.Fourth Quarter FY2019 SnapshotFourth quarter organic growth of 7% (6% reported) to $191.7 million. Full year o

CONCORD, Calif., Aug. 6, 2019 /PRNewswire/ -- Today, Nonstop Administration and Insurance Services, Inc. (Nonstop), a nontraditional health insurance broker committed to reducing barriers to quality, affordable healthcare through first dollar coverage, is announcing a new alignment of like-minded organizations committed to helping California

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 6, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 20

LOS ANGELES, Aug. 6, 2019 /PRNewswire/ -- Jessica Billingsley is determined not to be the only CEO of a NASDAQ-traded cannabis technology company for long. Since taking the helm of Akerna Corp. in June, Billingsley has been on dual missions: Expand the $72 billion company and encourage tech and cannabis compan

RADNOR, Pa., Aug. 6, 2019 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today reported financial results for the quarter ended June 30, 2019."Following our outstanding

FRANKLIN LAKES, N.J., Aug. 6, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.350 billion for the third fiscal quarter ended June 30, 2019.  This represents an increase of 1.7 percent over the prior-year period.  On a comparable, c

BRAINTREE, Mass., Aug. 6, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its first quarter of fiscal 2020, which ended June 29, 2019, are available on its Investor Relations website.

Emerging from 15 years of Dr. Jacques Ravel's vaginal microbiome research, LUCA's pipeline targets UTI, bacterial vaginosis (BV), and preterm birth (PTB) CAMBRIDGE, Mass., Aug. 6, 2019 /PRNewswire/ -- LUCA Biologics, a biotechnology company co-founded by Dr. Jacques Ravel, announced toda